For citations:
Beketova T.V., Levina N.О., Dubinskaia M.V., Uskova Yu.A., Rozanova I.V., Babak V.V., Beketova M.F., Krasnova T.N. Experience with Tixagevimab and Cilgavimab (Evusheld) in 86 rheumatic patients undergoing anti-B cell therapy with rituximab. Rheumatology Science and Practice. 2023;61(2):158-164. (In Russ.) https://doi.org/10.47360/1995-4484-2023-158-164